HPA__HDAC inhibitor Lenalidomide
Product Name
HPA
Description
HDAC inhibitor
Purity
>97% (TLC), NMR conforms
CAS No.
96017-59-3
Molecular Formula
C11H11O2
Molecular Weight
182.3
Storage Temperature
-20ºC
Shipping Temperature
Shipped Ambient
Product Type
Inhibitor
Solubility
Soluble in 25 mg/ml DMSO or 25 mg/ml Ethanol
Source
Synthetic
Appearance
Colorless Oil
SMILES
O=C(O)C(CCCCCC)CC#C
InChI
InChI=1S/C11H18O2/c1-3-5-6-7-9-10(8-4-2)11(12)13/h2,10H,3,5-9H2,1H3,(H,12,13)
InChIKey
DUQSBRQHALCSLC-UHFFFAOYSA-N
Safety Phrases
Classification: Caution- Substance not yet fully tested.
Safety Phrases:
S22 – Do not breathe dust
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection
S24/25- Avoid contact with skin and eyes
Cite This Product
HPA (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-356)
References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/19129450
Alternative Names
2-(2-propynyl)octanoic acid, HPA
Research Areas
Cancer, Cell Signaling, Epigenetics
PubChem ID
175664
Scientific Background
Histone deacetylase (HDAC) inhibitor, IC50=13 µM Histone deacetylase (HDAC) inhibitor, IC50=13 µM
References
1. Eikel D., et al. (2006) Chem. Res. Toxicol. 19: 272.
2. Leng Y., et al. (2010) Neurosci. Lett. 476: 127.
HDAC inhibitor
Safety Phrases:
S22 – Do not breathe dust
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection
S24/25- Avoid contact with skin and eyes
2. Leng Y., et al. (2010) Neurosci. Lett. 476: 127.